The Philippines is witnessing a rapid rise in HIV infections, recording a 543% rise in cases between 2010 and 2023. One in ...

Undeterred by last year’s rejection and the recent approval of a close rival from Pfizer, Novo Nordisk has pushed its ...

Implementation of a time-out checklist in the trauma bay may encourage compliance with guideline recommendations for ...

Extracellular vesicles (EVs) have emerged as a transformative platform in biomedical research, especially in the domains of diagnosis, prophylaxis, and ...

From GLP-1RA and HIV PrEP successes, to flops in DMD and Alzheimer’s, Clinical Trials Arena rounds up the biggest trial read ...

Novo Nordisk (NVO) wins U.S. FDA nod for its Alhemo injection as a once-daily prophylaxis for bleeding prevention in patients ...

A phase 3 clinical trial, explorer8, has demonstrated the efficacy and safety of concizumab, a monoclonal antibody in ...

Historically, sickle cell anaemia has been widely neglected within its global epicentre of sub-Saharan Africa. More than ...

Altuviiio (efanesoctocog alfa) may work better than other treatments as a hemophilia A factor replacement therapy, a study ...

Emergent BioSolutions (NYSE:EBS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Friday.

Botox is effective for migraine prevention. Sufferers of chronic migraine experienced fewer headache days per month while ...

A national survey of Canadian hematologists reveals gaps and variability in supportive care strategies for older adults with ...